Phase 2 Study of Cemiplimab in Patients with Advanced Cutaneous Squamous Cell Carcinoma (CSCC): Longer Follow-Up. (2020). SKIN The Journal of Cutaneous Medicine, 4(6), s124. https://doi.org/10.25251/skin.4.supp.124